United States Healthcare Equipment & Supplies

Vivos Therapeutics Inc (VVOS)

Track

Track

Vivos Therapeutics Inc. recorded significant insider trading activity on March 31, 2026, when Michael C. Skaff executed multiple purchase orders totaling over 2.2 million dollars. These acquisitions represent the most recent documented transactions for the firm. No further buying or selling by company officials has occurred within the last three months.
Ticker: VVOS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vivos Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Skaff Michael C Large shareholder
Transaction date
Purchase
Price
16.60
Quantity 10,820 -9.7%
Value US$1,198,854
Skaff Michael C Large shareholder
Transaction date
Purchase
Price
392.84
Quantity 33,408 -9.7%
Value US$2,174,082
Skaff Michael C Large shareholder
Transaction date
Purchase
Price
454.97
Quantity 23,740 +45.2%
Value US$1,565,783
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.53
Quantity 14,000 +19.3%
Value US$7,420
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.53
Quantity 5,000 +7.4%
Value US$2,650
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.54
Quantity 10,000 +17.4%
Value US$5,400
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.50
Quantity 21 +0.0%
Value US$10
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.49
Quantity 10,000 +21.1%
Value US$4,900
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.50
Quantity 20,000 +72.7%
Value US$10,000
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.83
Quantity 4,000 +17.0%
Value US$7,320
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.03
Quantity 8,000 +51.6%
Value US$16,240
1.9
Amman Bradford K. Chief Financial Officer Officer
Transaction date
Purchase
Price
5.29
Quantity 1,000 +100.0%
Value US$5,290
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.38
Quantity 4,000 +266.7%
Value US$21,520
1.9
Amman Bradford K. Chief Financial Officer Officer
Transaction date
Purchase
Price
7.38
Quantity 1,000 +inf%
Value US$7,380
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
7.27
Quantity 1,000 +200.0%
Value US$7,267
2.1
Huntsman Ronald Kirk Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
8.50
Quantity 500 +inf%
Value US$4,250
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
10,820 -9.7%
16.60
US$1,198,854 		10,820 -9.7% 16.60 US$1,198,854
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
33,408 -9.7%
392.84
US$2,174,082 		33,408 -9.7% 392.84 US$2,174,082
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
23,740 +45.2%
454.97
US$1,565,783 		23,740 +45.2% 454.97 US$1,565,783
2023-06-20 2023-06-20 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
14,000 +19.3%
0.53
US$7,420 		14,000 +19.3% 0.53 US$7,420
2023-06-20 2023-06-16 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
5,000 +7.4%
0.53
US$2,650 		5,000 +7.4% 0.53 US$2,650
2023-06-20 2023-06-16 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
10,000 +17.4%
0.54
US$5,400 		10,000 +17.4% 0.54 US$5,400
2023-06-20 2023-06-15 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
21 +0.0%
0.50
US$10 		21 +0.0% 0.50 US$10
2023-06-15 2023-06-14 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
10,000 +21.1%
0.49
US$4,900 		10,000 +21.1% 0.49 US$4,900
2022-12-28 2022-12-23 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
20,000 +72.7%
0.50
US$10,000 		20,000 +72.7% 0.50 US$10,000
2022-06-03 2022-06-01 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
4,000 +17.0%
1.83
US$7,320 		4,000 +17.0% 1.83 US$7,320
2022-06-03 2022-05-31 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
8,000 +51.6%
2.03
US$16,240 		8,000 +51.6% 2.03 US$16,240
2021-05-25 2021-05-25 B Purchase
1.9
Amman Bradford K.

Chief Financial Officer

Officer
1,000 +100.0%
5.29
US$5,290 		1,000 +100.0% 5.29 US$5,290
2021-05-25 2021-05-25 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
4,000 +266.7%
5.38
US$21,520 		4,000 +266.7% 5.38 US$21,520
2020-12-28 2020-12-24 B Purchase
1.9
Amman Bradford K.

Chief Financial Officer

Officer
1,000 +inf%
7.38
US$7,380 		1,000 +inf% 7.38 US$7,380
2020-12-23 2020-12-23 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
1,000 +200.0%
7.27
US$7,267 		1,000 +200.0% 7.27 US$7,267
2020-12-14 2020-12-11 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
500 +inf%
8.50
US$4,250 		500 +inf% 8.50 US$4,250
Explore more

More insider trading research around Vivos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America